What is Clofuzid used for?

Clofuzid is indicated for Pityriasis simplex, Seborrheic dermatitis.

What development phase is Clofuzid in?

Clofuzid is FDA-approved (marketed).

What is the generic name of Clofuzid?

CHLOROXINE is the generic (nonproprietary) name of Clofuzid.

Last reviewed 2026-04-20 · How we verify

Clofuzid (CHLOROXINE)

FDA-approved approved Small molecule Quality 35/100

Clofuzine, also known as Chloroxine, is a small molecule drug that targets Arachidonate 12-lipoxygenase, 12S-type. It was originally developed and is currently owned by a pharmaceutical company. Clofuzine is used to treat Pityriasis simplex and Seborrheic dermatitis, and was FDA approved in 1976. The drug is off-patent and has no active Orange Book patents, meaning it can be manufactured by generic manufacturers. Key safety considerations include its bioavailability of 89%.

At a glance

Generic name	CHLOROXINE
Drug class	chloroxine
Target	Arachidonate 12-lipoxygenase, 12S-type
Modality	Small molecule
Therapeutic area	Dermatology
Phase	FDA-approved
First approval	1976

Approved indications

Pityriasis simplex
Seborrheic dermatitis

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Clofuzid CI brief — competitive landscape report
Clofuzid updates RSS · CI watch RSS